Zoetis | ZTS - Current Liabilities



Zoetis reported $3.37B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
Align Technology USD 2B 4.54M Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Dentsply International USD 1.17B 627M Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Henry Schein USD 3.01B 90M Jun/2025
Idexx Laboratories USD 1.22B 87.67M Jun/2025
Illumina USD 1.46B 21M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Laboratory Of America USD 2.72B 652.2M Jun/2025
Merck USD 26.04B 863M Jun/2025
Neogen USD 174.01M 32.81M May/2025
Pacira USD 313.16M 1.57M Jun/2025
Perrigo USD 1.13B 52.3M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Quest Diagnostics USD 2.02B 583M Jun/2025
Sanofi 29.06B 3.16B Jun/2025
Sanofi 29.06B 103M Jun/2025
Zoetis USD 3.37B 19M Jun/2025